Proto Axiom

Proto Axiom is an Australian biotechnology company and venture incubator focused on the commercialization of medical research from top-tier academic institutions. The company operates a unique model that combines early-stage funding with operational expertise to bridge the gap between laboratory discovery and clinical application. By partnering with major Australian universities, Proto Axiom identifies high-potential intellectual property and develops it through dedicated spin-out companies. Their portfolio encompasses a range of modalities including small molecules and synthetic biology, primarily targeting unmet needs in oncology and infectious diseases. The firm provides the necessary infrastructure and strategic guidance to transform scientific breakthroughs into market-ready healthcare solutions while strengthening the local biotech ecosystem.